Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

BioStock: Fluicell dives into regenerative medicine field

Fluicell
Read the release

Regenerative medicine is an emerging field of research that focuses on the repair, replacement or regeneration of cells, tissues or organs to restore impaired function. The field has the potential to address a sizeable market and have a significant impact on the healthcare industry by reducing the burden of certain diseases or conditions where tissue damage is involved. R&D company Fluicell aims to enter this market by focusing on the development of advanced therapy medicinal products (ATMP) based on transplantable microtissues using the company's lead product, Biopixlar. BioStock spoke with Fluicell's CEO Victoire Viannay to learn more about the initiative and its potential impact. 

Read the full interview with Victoire Viannay at biostock.se:

https://www.biostock.se/en/fluicell-dives-into-regenerative-medicine-field/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.